127 related articles for article (PubMed ID: 32403994)
21. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.
Vaz J; Tian C; Richardson MT; Chan JK; Mysona D; Rao UN; Powell MA; Shriver CD; Hamilton CA; Casablanca Y; Maxwell GL; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):121-130. PubMed ID: 31954536
[TBL] [Abstract][Full Text] [Related]
22. Leiomyosarcoma of the uterine cervix.
Kasamatsu T; Shiromizu K; Takahashi M; Kikuchi A; Uehara T
Gynecol Oncol; 1998 May; 69(2):169-71. PubMed ID: 9600826
[TBL] [Abstract][Full Text] [Related]
23. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
[TBL] [Abstract][Full Text] [Related]
24. Occult invasive cervical cancer after simple hysterectomy: a multi-center retrospective study of 89 cases.
Bai H; Cao D; Yuan F; Wang H; Chen J; Wang Y; Shen K; Zhang Z
BMC Cancer; 2016 Jul; 16():507. PubMed ID: 27439407
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
26. Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
Mahdavi A; Monk BJ; Ragazzo J; Hunter MI; Lentz SE; Vasilev SA; Tewari KS
Int J Gynecol Cancer; 2009 Aug; 19(6):1080-4. PubMed ID: 19820372
[TBL] [Abstract][Full Text] [Related]
27. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
Casarin J; Buda A; Bogani G; Fanfani F; Papadia A; Ceccaroni M; Malzoni M; Pellegrino A; Ferrari F; Greggi S; Uccella S; Pinelli C; Cromi A; Ditto A; Di Martino G; Anchora LP; Falcone F; Bonfiglio F; Odicino F; Mueller M; Scambia G; Raspagliesi F; Landoni F; Ghezzi F
Gynecol Oncol; 2020 Oct; 159(1):164-170. PubMed ID: 32665147
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
Sorbe B; Johansson B
Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
[TBL] [Abstract][Full Text] [Related]
29. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
[TBL] [Abstract][Full Text] [Related]
30. Tailored radical hysterectomy for locally advanced cervical cancer.
Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
[TBL] [Abstract][Full Text] [Related]
31. [Sarcoma botryoides (embryonal rhabdomyosarcoma) as an unusual diagnosis of cervix polyps].
Kaserer K; Kainz C; Reinthaller A; Amann G; Beer F; Breitenecker G
Pathologe; 1995 Jul; 16(4):287-91. PubMed ID: 7667212
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
33. Epithelioid leiomyosarcoma of the uterine cervix: a case report and review of the literature.
Toyoshima M; Okamura C; Niikura H; Ito K; Yaegashi N
Gynecol Oncol; 2005 Jun; 97(3):957-60. PubMed ID: 15890394
[TBL] [Abstract][Full Text] [Related]
34. [PROGNOSTIC GROUPS FOR RELAPSE IN STAGE IB1 CERVICAL CANCER].
Ismail E; Kornovski Y; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(6):28-34. PubMed ID: 26817260
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications.
Chatani M; Nose T; Masaki N; Inoue T
Strahlenther Onkol; 1998 Oct; 174(10):504-9. PubMed ID: 9810317
[TBL] [Abstract][Full Text] [Related]
36. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
[TBL] [Abstract][Full Text] [Related]
37. [PROGNOSTIC SIGNIFICANCE OF ADJUVANT RADIOTHERAPY IN EARLY IB1 STAGE CERVICAL CANCER].
Ismail E; Kornovski Y
Akush Ginekol (Sofiia); 2015; 54(6):16-23. PubMed ID: 26817258
[TBL] [Abstract][Full Text] [Related]
38. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.
Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838
[TBL] [Abstract][Full Text] [Related]
39. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
[TBL] [Abstract][Full Text] [Related]
40. Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.
Jung PS; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
PLoS One; 2015; 10(7):e0132298. PubMed ID: 26176626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
